Symbols / TSHA Stock $6.33 -0.94% Taysha Gene Therapies, Inc.

Healthcare • Biotechnology • United States • NMS
TSHA (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index —
Sector Healthcare
Industry Biotechnology
CEO —
Exch · Country NMS · United States
Market Cap 1.82B
Enterprise Value —
Income —
Sales —
FCF (ttm) —
Book/sh —
Cash/sh —
Employees —
Insider 10d —
IPO —
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout —
P/E —
Forward P/E —
PEG —
P/S —
P/B —
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio —
Current Ratio —
Debt/Eq —
LT Debt/Eq —
EPS (ttm) —
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA —
ROE —
ROIC —
Gross Margin —
Oper. Margin —
Profit Margin —
Shs Outstand —
Shs Float —
Insider Own —
Instit Own —
Short Float —
Short Ratio —
Short Interest —
52W High —
vs 52W High —
52W Low —
vs 52W Low —
Beta —
Impl. Vol. —
Rel Volume —
Avg Volume —
Volume —
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom —
Prev Close $6.39
Price $6.33
Change -0.94%
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest TSHA news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
9.77
+17.28%
8.33
-46.07%
15.45
+517.55%
2.50
Operating Revenue
9.77
+17.28%
8.33
-46.07%
15.45
+517.55%
2.50
Operating Expense
120.27
+26.66%
94.95
+9.36%
86.83
-32.45%
128.53
Research And Development
86.40
+30.91%
66.00
+16.24%
56.78
-37.72%
91.17
Selling General And Administration
33.87
+16.98%
28.95
-3.64%
30.05
-19.57%
37.36
General And Administrative Expense
33.87
+16.98%
28.95
-3.64%
30.05
-19.57%
37.36
Other Gand A
33.87
+16.98%
28.95
-3.64%
30.05
-19.57%
37.36
Total Expenses
120.27
+26.66%
94.95
+9.36%
86.83
-32.45%
128.53
Operating Income
-110.50
-27.56%
-86.62
-21.36%
-71.37
+43.37%
-126.03
Total Operating Income As Reported
-110.50
-20.82%
-91.46
-26.26%
-72.44
+55.41%
-162.45
EBITDA
-107.79
-22.55%
-87.95
+16.39%
-105.20
+34.68%
-161.04
Normalized EBITDA
-106.59
-28.22%
-83.13
-22.22%
-68.02
+45.42%
-124.62
Reconciled Depreciation
1.15
-8.03%
1.25
-9.19%
1.37
+16.98%
1.17
EBIT
-108.93
-22.13%
-89.20
+16.30%
-106.57
+34.30%
-162.22
Total Unusual Items
-1.20
+75.13%
-4.82
+87.03%
-37.18
-2.09%
-36.42
Total Unusual Items Excluding Goodwill
-1.20
+75.13%
-4.82
+87.03%
-37.18
-2.09%
-36.42
Special Income Charges
0.00
+100.00%
-4.84
-96.43%
-2.46
+93.24%
-36.42
Other Special Charges
—
—
1.40
—
Impairment Of Capital Assets
0.00
-100.00%
4.84
+354.27%
1.06
-97.08%
36.42
Net Income
-109.00
-22.06%
-89.30
+19.96%
-111.57
+32.80%
-166.01
Pretax Income
-109.00
-22.06%
-89.30
+19.96%
-111.57
+32.80%
-166.01
Net Non Operating Interest Income Expense
9.16
+33.97%
6.84
+579.52%
-1.43
+59.82%
-3.55
Interest Expense Non Operating
0.06
-38.24%
0.10
-97.96%
5.00
+31.60%
3.80
Net Interest Income
9.16
+33.97%
6.84
+579.52%
-1.43
+59.82%
-3.55
Interest Expense
0.06
-38.24%
0.10
-97.96%
5.00
+31.60%
3.80
Interest Income Non Operating
9.22
+32.91%
6.94
+94.29%
3.57
+1334.54%
0.25
Interest Income
9.22
+32.91%
6.94
+94.29%
3.57
+1334.54%
0.25
Other Income Expense
-7.66
+19.52%
-9.52
+75.46%
-38.77
-6.39%
-36.44
Other Non Operating Income Expenses
-6.46
-37.63%
-4.69
-196.09%
-1.58
-8705.56%
-0.02
Gain On Sale Of Security
-1.20
-7593.75%
0.02
+100.05%
-34.72
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-109.00
-22.06%
-89.30
+19.96%
-111.57
+32.80%
-166.01
Net Income From Continuing Operation Net Minority Interest
-109.00
-22.06%
-89.30
+19.96%
-111.57
+32.80%
-166.01
Net Income From Continuing And Discontinued Operation
-109.00
-22.06%
-89.30
+19.96%
-111.57
+32.80%
-166.01
Net Income Continuous Operations
-109.00
-22.06%
-89.30
+19.96%
-111.57
+32.80%
-166.01
Normalized Income
-107.80
-27.61%
-84.48
-13.57%
-74.39
+42.60%
-129.59
Net Income Common Stockholders
-109.00
-22.06%
-89.30
+19.96%
-111.57
+32.80%
-166.01
Diluted EPS
—
-0.36
+62.50%
-0.96
+74.60%
-3.78
Basic EPS
—
-0.36
+62.50%
-0.96
+74.60%
-3.78
Basic Average Shares
—
250.13
+115.41%
116.12
+164.20%
43.95
Diluted Average Shares
—
250.13
+115.41%
116.12
+164.20%
43.95
Diluted NI Availto Com Stockholders
-109.00
-22.06%
-89.30
+19.96%
-111.57
+32.80%
-166.01
Line Item Trend 2023-12-31
Total Assets
172.73
Current Assets
149.87
Cash Cash Equivalents And Short Term Investments
143.94
Cash And Cash Equivalents
143.94
Cash Equivalents
142.43
Cash Financial
1.51
Prepaid Assets
2.51
Current Deferred Assets
0.68
Restricted Cash
0.45
Assets Held For Sale Current
2.00
Other Current Assets
0.29
Total Non Current Assets
22.86
Net PPE
20.41
Gross PPE
23.39
Accumulated Depreciation
-2.98
Properties
0.00
Machinery Furniture Equipment
2.00
Construction In Progress
6.82
Other Properties
12.45
Leases
2.12
Non Current Deferred Assets
—
Other Non Current Assets
2.46
Total Liabilities Net Minority Interest
97.79
Current Liabilities
36.76
Payables And Accrued Expenses
12.01
Payables
6.37
Accounts Payable
6.37
Current Accrued Expenses
5.65
Pensionand Other Post Retirement Benefit Plans Current
3.81
Current Debt And Capital Lease Obligation
1.65
Current Capital Lease Obligation
1.65
Current Deferred Liabilities
18.11
Current Deferred Revenue
18.11
Other Current Liabilities
1.18
Total Non Current Liabilities Net Minority Interest
61.04
Long Term Debt And Capital Lease Obligation
59.46
Long Term Debt
40.51
Long Term Capital Lease Obligation
18.95
Other Non Current Liabilities
1.58
Stockholders Equity
74.94
Common Stock Equity
74.94
Capital Stock
0.00
Common Stock
0.00
Preferred Stock
0.00
Share Issued
186.96
Ordinary Shares Number
186.96
Treasury Shares Number
0.00
Additional Paid In Capital
587.94
Retained Earnings
-513.01
Gains Losses Not Affecting Retained Earnings
0.00
Other Equity Adjustments
—
Total Equity Gross Minority Interest
74.94
Total Capitalization
115.44
Working Capital
113.11
Invested Capital
115.44
Total Debt
61.11
Capital Lease Obligations
20.60
Net Tangible Assets
74.94
Tangible Book Value
74.94
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-93.09
-14.61%
-81.22
-11.24%
-73.02
+17.39%
-88.39
Cash Flow From Continuing Operating Activities
-93.09
-14.61%
-81.22
-11.24%
-73.02
+17.39%
-88.39
Net Income From Continuing Operations
-109.00
-22.06%
-89.30
+19.96%
-111.57
+32.80%
-166.01
Depreciation Amortization Depletion
1.15
-8.03%
1.25
-9.19%
1.37
+16.98%
1.17
Depreciation
1.15
-8.03%
1.25
-9.19%
1.37
+16.98%
1.17
Depreciation And Amortization
1.15
-8.03%
1.25
-9.19%
1.37
+16.98%
1.17
Other Non Cash Items
5.63
+311.24%
1.37
-85.22%
9.27
+167.01%
3.47
Stock Based Compensation
13.30
+1.49%
13.10
+65.76%
7.91
-56.19%
18.04
Asset Impairment Charge
0.00
-100.00%
4.84
+354.27%
1.06
-97.08%
36.42
Operating Gains Losses
1.20
+7593.75%
-0.02
-100.04%
36.95
—
Gain Loss On Investment Securities
1.20
+7593.75%
-0.02
-100.04%
35.59
—
Change In Working Capital
-5.37
+56.92%
-12.47
+30.79%
-18.01
-197.27%
18.52
Change In Prepaid Assets
-1.73
-937.68%
0.21
-96.56%
6.01
+187.88%
2.09
Change In Payables And Accrued Expense
6.14
+241.35%
-4.34
+49.36%
-8.57
+49.95%
-17.13
Change In Accrued Expense
6.29
+542.58%
-1.42
+77.36%
-6.28
+32.67%
-9.32
Change In Payable
-0.15
+94.76%
-2.92
-27.23%
-2.29
+70.59%
-7.80
Change In Account Payable
-0.15
+94.76%
-2.92
-27.23%
-2.29
+70.59%
-7.80
Change In Other Working Capital
-9.77
-17.28%
-8.33
+46.07%
-15.45
-146.04%
33.56
Investing Cash Flow
-0.60
-66.39%
-0.36
+95.06%
-7.35
+70.51%
-24.93
Cash Flow From Continuing Investing Activities
-0.60
-66.39%
-0.36
+95.06%
-7.35
+70.51%
-24.93
Net PPE Purchase And Sale
-0.74
-97.33%
-0.37
+90.33%
-3.87
+81.24%
-20.62
Purchase Of PPE
-0.74
-97.33%
-0.37
+90.33%
-3.87
+81.24%
-20.62
Capital Expenditure
-0.74
-97.33%
-0.37
+94.92%
-7.37
+70.37%
-24.87
Net Intangibles Purchase And Sale
—
0.00
+100.00%
-3.50
+17.65%
-4.25
Purchase Of Intangibles
—
0.00
+100.00%
-3.50
+17.65%
-4.25
Net Other Investing Changes
0.13
+1118.18%
0.01
-35.29%
0.02
+127.87%
-0.06
Financing Cash Flow
274.59
+258.08%
76.68
-43.78%
136.39
+161.81%
52.10
Cash Flow From Continuing Financing Activities
274.59
+258.08%
76.68
-43.78%
136.39
+161.81%
52.10
Net Issuance Payments Of Debt
9.24
0.00
+100.00%
-3.45
0.00
Issuance Of Debt
49.85
0.00
-100.00%
39.55
0.00
Repayment Of Debt
-40.61
0.00
+100.00%
-43.00
0.00
Long Term Debt Issuance
49.85
0.00
-100.00%
39.55
0.00
Long Term Debt Payments
-40.61
0.00
+100.00%
-43.00
0.00
Net Long Term Debt Issuance
9.24
0.00
+100.00%
-3.45
0.00
Net Common Stock Issuance
264.31
+244.24%
76.78
-45.46%
140.79
+164.42%
53.24
Proceeds From Stock Option Exercised
1.38
+1449.44%
0.09
+30.88%
0.07
-73.12%
0.25
Net Other Financing Charges
-0.34
-82.16%
-0.18
+81.77%
-1.01
+27.50%
-1.40
Changes In Cash
180.90
+3788.72%
-4.90
-108.75%
56.02
+191.51%
-61.22
Beginning Cash Position
141.64
-3.35%
146.54
+61.89%
90.52
-40.35%
151.74
End Cash Position
322.53
+127.72%
141.64
-3.35%
146.54
+61.89%
90.52
Free Cash Flow
-93.83
-14.99%
-81.60
-1.51%
-80.39
+29.02%
-113.26
Interest Paid Supplemental Data
5.40
+2.22%
5.28
+6.66%
4.95
+78.45%
2.77
Common Stock Issuance
264.31
+244.24%
76.78
-45.46%
140.79
+164.42%
53.24
Issuance Of Capital Stock
264.31
+244.24%
76.78
-45.46%
140.79
+164.42%
53.24
Net Preferred Stock Issuance
—
—
—
—
Preferred Stock Issuance
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category